Management Rights Letter

MANAGEMENT RIGHTS LETTER

MANAGEMENT RIGHTS LETTER

[DATE]

[INVESTOR NAME]
[INVESTOR ADDRESS]
[CITY, STATE ZIP]

Re: Management Rights - Investment in [COMPANY NAME]

Dear [INVESTOR CONTACT NAME]:

Reference is made to that certain Series [A] Preferred Stock Purchase Agreement dated [DATE] (the "Purchase Agreement") by and among [COMPANY NAME], a Delaware corporation (the "Company"), and the investors listed therein, including [INVESTOR NAME] (the "Investor"). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Purchase Agreement.

In consideration of the Investor's agreement to purchase shares of Series [A] Preferred Stock of the Company pursuant to the Purchase Agreement, the Company hereby agrees as follows:

1. MANAGEMENT RIGHTS

1.1 Consultation Rights

(a) The Company grants the Investor contractual rights directly between the Investor and the Company to consult with, advise, and substantially influence the conduct of the Company's management on significant business issues, including:

• (i) Strategic planning and business development;
• (ii) Financial performance and budgeting;
• (iii) Product development and technology strategy;
• (iv) Marketing and sales strategy;
• (v) Human resources and key hiring decisions;
• (vi) Fundraising and capital structure;
• (vii) Mergers, acquisitions, and strategic partnerships;
• (viii) Such other matters as may be mutually agreed.

(b) The Company's management shall make itself reasonably available to consult with the Investor's designated representative(s) on such matters upon reasonable notice.

1.2 Information Rights

(a) The Investor shall have the right to receive from the Company:

• (i) Annual Financial Statements: Audited annual financial statements within [90-120] days after fiscal year end;
• (ii) Quarterly Financial Statements: Unaudited quarterly financial statements within [45] days after quarter end;
• (iii) Annual Budget: The annual budget and business plan, as approved by the Board;
• (iv) Monthly Reports: Monthly financial reports within [30] days of month end (if prepared);
• (v) Board Materials: Copies of materials provided to the Board of Directors;
• (vi) Capitalization Table: Updated capitalization table upon request;
• (vii) Other Information: Such other information as may be reasonably requested.

(b) The information rights granted herein are in addition to any information rights granted under the Investors' Rights Agreement.

(c) The Company may withhold or redact information to the extent reasonably necessary to preserve attorney-client privilege or work-product protection, comply with law or a binding confidentiality obligation, address an actual conflict of interest, or protect competitively sensitive information. The Company shall use reasonable efforts to provide a nonprivileged summary or other protective arrangement when practicable.

1.3 Access Rights

(a) The Company shall permit the Investor's designated representative(s) to:

• (i) Visit and inspect the Company's properties and facilities during normal business hours upon reasonable advance notice;
• (ii) Meet with Company management to discuss the Company's business and operations;
• (iii) Examine the Company's books and records;
• (iv) Discuss the Company's affairs, finances, and accounts with Company officers and independent accountants.

(b) Such access shall be provided at reasonable times and in a manner that does not unreasonably interfere with the Company's business operations.

1.4 Board Observer Rights

(a) For so long as the Investor holds at least [THRESHOLD] shares of the Company's capital stock, the Investor shall have the right to designate one representative to attend all meetings of the Board of Directors as a non-voting observer (the "Observer").

(b) The Company shall provide the Observer with:

• (i) Notice of all Board meetings at the same time as notice is provided to directors;
• (ii) Copies of all materials provided to the Board;
• (iii) Access to attend Board meetings in person or by telephone/video conference.

(c) The Observer may be excluded from portions of Board meetings involving:

• (i) Matters in which the Investor has a conflict of interest;
• (ii) Attorney-client privileged communications; or
• (iii) Matters where attendance would violate law or a binding confidentiality obligation; or
• (iv) Competitively sensitive matters where attendance would reasonably risk material harm to the Company.

(d) The Observer is not a director, has no vote or consent right in that capacity, and shall not be counted for quorum. Observer rights do not transfer the Board's management authority.

1.5 Board Seat (If Applicable)

☐ Board Seat Included: If the Voting Agreement and the Company's certificate of incorporation or bylaws validly provide the designation right, the Investor may designate one candidate for election to the Board. Once duly elected, the designee is a director—not an observer—and participates in the Board's management of the Company under 8 Del. C. § 141(a), subject to applicable duties and the Company's organizational documents.

2. VCOC QUALIFICATION

2.1 Purpose

The Investor represents that it is evaluating or maintaining status as a venture capital operating company ("VCOC"). This letter is intended to create "management rights" within 29 C.F.R. § 2510.3-101(d)(3)(ii): contractual rights directly between the Investor and the Company to substantially participate in, or substantially influence, the conduct of the Company's management. ERISA's statutory plan-assets definition appears at 29 U.S.C. § 1002(42).

2.2 Separate VCOC Requirements

This letter supplies only the contractual-rights component of the VCOC analysis. Under 29 C.F.R. § 2510.3-101(d)(1), VCOC status also requires, among other things:

• (a) At least 50% of the Investor's assets, excluding specified short-term investments and valued at cost, must be invested in qualifying venture capital investments or derivative investments on the applicable initial valuation date or during the applicable annual valuation period; and
• (b) In the ordinary course of business, the Investor must actually exercise qualifying management rights with respect to one or more operating companies during the applicable measurement period.

The Investor is solely responsible for determining its initial valuation date, establishing and consistently applying its annual valuation period under 29 C.F.R. § 2510.3-101(d)(5), testing its assets, and exercising and documenting management rights.

2.3 Exercise and Documentation

The Company shall make management reasonably available for the consultations contemplated by this letter and shall cooperate with reasonable requests to document the Investor's actual exercise of these rights. The Investor shall maintain its own records of consultations, advice, attendance, requests, and other exercises of management rights.

2.4 No Qualification Representation

Neither the Company nor this letter represents or guarantees that the Investor is or will remain a VCOC, that any investment is a qualifying venture capital investment, or that the Investor satisfies the asset, timing, actual-exercise, or other requirements of 29 C.F.R. § 2510.3-101(d). If counsel determines that these contractual rights should be revised, the parties shall consider a good-faith amendment that does not unreasonably burden the Company.

3. CONFIDENTIALITY

3.1 Confidential Information

The Investor agrees to maintain the confidentiality of all non-public information received from the Company pursuant to this letter and to use such information solely for the purpose of monitoring and advising on its investment in the Company.

3.2 Disclosure to Limited Partners

Notwithstanding Section 3.1, the Investor may disclose confidential information to:

• (a) Its partners, members, directors, officers, and employees who have a need to know;
• (b) Its legal, financial, and tax advisors;
• (c) Its limited partners and investors, subject to confidentiality obligations;
• (d) Prospective purchasers of the Investor's interest in the Company, subject to confidentiality obligations.

4. DURATION

4.1 Effectiveness

This letter shall become effective upon the closing of the Investor's purchase of Series [A] Preferred Stock pursuant to the Purchase Agreement.

4.2 Termination

This letter shall terminate upon the earliest of:

• (a) The closing of the Company's initial public offering;
• (b) The Investor ceasing to hold any shares of the Company's capital stock;
• (c) The written agreement of the Company and the Investor.

5. GENERAL PROVISIONS

5.1 No Employment Relationship

Nothing in this letter shall be construed to create an employment, agency, or partnership relationship between the Company and the Investor or its representatives.

5.2 No Fiduciary Duty

The parties do not intend consultation or observer status alone to appoint the Investor as an officer, director, employee, or agent of the Company. This Section does not limit any duty or liability arising under applicable law from actual control, Board service, a separate relationship, fraud, gross negligence, or willful misconduct.

5.3 Assignment

The Investor may assign its rights under this letter to any affiliate of the Investor or to any transferee of all or substantially all of the Investor's shares of the Company's capital stock, provided that such transferee agrees in writing to be bound by the terms of this letter.

5.4 Amendment

This letter may be amended only by a written instrument signed by both parties.

5.5 Governing Law

This letter shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to conflict of laws principles.

5.6 Counterparts

This letter may be executed in counterparts, each of which is deemed an original and all of which together constitute one instrument. The parties may sign electronically to the extent permitted by applicable law.

6. ACKNOWLEDGMENT

Please indicate your acceptance of the foregoing by signing and returning a copy of this letter.

COMPANY:

[COMPANY NAME]

By: _________________________________

Name: [AUTHORIZED SIGNATORY NAME]

Title: [TITLE]

Date: _________________________________

ACKNOWLEDGED AND AGREED:

INVESTOR:

[INVESTOR NAME]

By: _________________________________

Name: [AUTHORIZED SIGNATORY NAME]

Title: [TITLE]

Date: _________________________________

SCHEDULE A - INVESTOR REPRESENTATIVE(S)

The Investor designates the following individual(s) as its representative(s) for purposes of exercising management rights under this letter:

The Investor may change its designated representative(s) by providing written notice to the Company.

SOURCES AND REFERENCES

• 29 C.F.R. § 2510.3-101 — Plan assets; VCOC requirements and management rights
• 29 U.S.C. § 1002(42) — Plan assets and benefit plan investors
• 8 Del. C. § 141 — Board management and director provisions

This letter creates contractual management rights; it does not by itself establish VCOC status. The Investor must separately satisfy and document the applicable asset, timing, and actual-exercise requirements. Qualified ERISA and corporate counsel should review the completed letter before use.